Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![justtmd_com Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1625741339651440642.png) TMD - The Market Daily [@justtmd_com](/creator/twitter/justtmd_com) on x XXX followers
Created: 2025-07-20 13:10:31 UTC

GLP-1 Weight Loss Drugs Show Promise in Treating PCOS Symptoms Despite Lack of FDA Approval.

GLP-1 drugs like Ozempic and Wegovy—originally for diabetes and weight loss—are showing promise in easing PCOS symptoms like weight gain, irregular periods, and insulin resistance. Though not FDA-approved for PCOS, early studies and patient reports point to improvements in hormone levels, acne, and menstrual regularity.

Roughly XX% of women with PCOS have insulin resistance, and these meds help regulate blood sugar and appetite—key issues in PCOS management. But insurance rarely covers off-label use, and monthly costs can exceed $XXXXX without coverage.

Despite limited research and ongoing shortages, momentum is growing. Researchers and users alike are pushing for further studies—and recognition—for these potential game-changers in PCOS care.



![](https://pbs.twimg.com/media/GwTaBPZWsAMBl6N.jpg)

XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1946920657096229047/c:line.svg)

**Related Topics**
[ozempic](/topic/ozempic)
[weight loss](/topic/weight-loss)

[Post Link](https://x.com/justtmd_com/status/1946920657096229047)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

justtmd_com Avatar TMD - The Market Daily @justtmd_com on x XXX followers Created: 2025-07-20 13:10:31 UTC

GLP-1 Weight Loss Drugs Show Promise in Treating PCOS Symptoms Despite Lack of FDA Approval.

GLP-1 drugs like Ozempic and Wegovy—originally for diabetes and weight loss—are showing promise in easing PCOS symptoms like weight gain, irregular periods, and insulin resistance. Though not FDA-approved for PCOS, early studies and patient reports point to improvements in hormone levels, acne, and menstrual regularity.

Roughly XX% of women with PCOS have insulin resistance, and these meds help regulate blood sugar and appetite—key issues in PCOS management. But insurance rarely covers off-label use, and monthly costs can exceed $XXXXX without coverage.

Despite limited research and ongoing shortages, momentum is growing. Researchers and users alike are pushing for further studies—and recognition—for these potential game-changers in PCOS care.

XX engagements

Engagements Line Chart

Related Topics ozempic weight loss

Post Link

post/tweet::1946920657096229047
/post/tweet::1946920657096229047